PURPOSE OF REVIEW: This review will highlight recent findings concerning the regulation and signalling of the intrarenal dopaminergic system and the emerging evidence for its importance in blood pressure regulation. RECENT FINDINGS: There is an increasing evidence that the intrarenal dopaminergic system plays an important role in the regulation of blood pressure, and defects in dopamine signalling appear to be involved in the development of hypertension. Recent experimental models have definitively demonstrated that abnormalities in intrarenal dopamine production or receptor signalling can predispose to salt-sensitive hypertension and a dysregulated renin-angiotensin system. There are also new results indicating the importance of dopamine receptor mediated regulation of salt and water homeostasis along the nephron, and new studies indicating the role that the intrarenal dopaminergic system plays to mitigate the production of reactive oxygen species and progression of chronic renal disease. SUMMARY: New studies underscore the importance of the intrarenal dopaminergic system in the regulation of renal function and indicate how alterations in dopamine production or signalling may underlie the development of hypertension and kidney injury.
PURPOSE OF REVIEW: This review will highlight recent findings concerning the regulation and signalling of the intrarenal dopaminergic system and the emerging evidence for its importance in blood pressure regulation. RECENT FINDINGS: There is an increasing evidence that the intrarenal dopaminergic system plays an important role in the regulation of blood pressure, and defects in dopamine signalling appear to be involved in the development of hypertension. Recent experimental models have definitively demonstrated that abnormalities in intrarenal dopamine production or receptor signalling can predispose to salt-sensitive hypertension and a dysregulated renin-angiotensin system. There are also new results indicating the importance of dopamine receptor mediated regulation of salt and water homeostasis along the nephron, and new studies indicating the role that the intrarenal dopaminergic system plays to mitigate the production of reactive oxygen species and progression of chronic renal disease. SUMMARY: New studies underscore the importance of the intrarenal dopaminergic system in the regulation of renal function and indicate how alterations in dopamine production or signalling may underlie the development of hypertension and kidney injury.
Authors: Xiaoyan Wang; Yingjin Luo; Crisanto S Escano; Zhiwei Yang; Laureano Asico; Hewang Li; John E Jones; Ines Armando; Quansheng Lu; David R Sibley; Gilbert M Eisner; Pedro A Jose Journal: Hypertension Date: 2010-04-19 Impact factor: 10.190
Authors: Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir Journal: Am J Physiol Renal Physiol Date: 2013-07-17
Authors: Maria M Federik Fernandez; Daniel Gonzalez; Jan M Williams; Richard J Roman; Susana Nowicki Journal: Eur J Pharmacol Date: 2012-05-02 Impact factor: 4.432
Authors: Yu Yang; Santiago Cuevas; Sufei Yang; Van Anthony Villar; Crisanto Escano; Laureano Asico; Peiying Yu; Xiaoliang Jiang; Edward J Weinman; Ines Armando; Pedro A Jose Journal: Hypertension Date: 2014-07-14 Impact factor: 10.190
Authors: Zhenyu Diao; Laureano D Asico; Van Anthony M Villar; Xiaoxu Zheng; Santiago Cuevas; Ines Armando; Pedro A Jose; Xiaoyan Wang Journal: Free Radic Biol Med Date: 2017-02-09 Impact factor: 7.376
Authors: Pierre-Jean Saulnier; Manjula Darshi; Kevin M Wheelock; Helen C Looker; Gudeta D Fufaa; William C Knowler; E Jennifer Weil; Stephanie K Tanamas; Kevin V Lemley; Rintaro Saito; Loki Natarajan; Robert G Nelson; Kumar Sharma Journal: Metabolomics Date: 2018-06-08 Impact factor: 4.290
Authors: Andrew C Tiu; Michael D Bishop; Laureano D Asico; Pedro A Jose; Van Anthony M Villar Journal: Curr Hypertens Rep Date: 2017-09 Impact factor: 5.369
Authors: Xiaoliang Jiang; Yanrong Zhang; Yu Yang; Jian Yang; Laureano D Asico; Wei Chen; Robin A Felder; Ines Armando; Pedro A Jose; Zhiwei Yang Journal: Am J Physiol Endocrinol Metab Date: 2016-10-25 Impact factor: 4.310